Correlation Between Q2 Holdings and COSCIENS Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Q2 Holdings and COSCIENS Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Q2 Holdings and COSCIENS Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Q2 Holdings and COSCIENS Biopharma, you can compare the effects of market volatilities on Q2 Holdings and COSCIENS Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Q2 Holdings with a short position of COSCIENS Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Q2 Holdings and COSCIENS Biopharma.

Diversification Opportunities for Q2 Holdings and COSCIENS Biopharma

-0.9
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between QTWO and COSCIENS is -0.9. Overlapping area represents the amount of risk that can be diversified away by holding Q2 Holdings and COSCIENS Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on COSCIENS Biopharma and Q2 Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Q2 Holdings are associated (or correlated) with COSCIENS Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of COSCIENS Biopharma has no effect on the direction of Q2 Holdings i.e., Q2 Holdings and COSCIENS Biopharma go up and down completely randomly.

Pair Corralation between Q2 Holdings and COSCIENS Biopharma

Given the investment horizon of 90 days Q2 Holdings is expected to under-perform the COSCIENS Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Q2 Holdings is 4.1 times less risky than COSCIENS Biopharma. The stock trades about -0.22 of its potential returns per unit of risk. The COSCIENS Biopharma is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  281.00  in COSCIENS Biopharma on October 7, 2024 and sell it today you would earn a total of  55.00  from holding COSCIENS Biopharma or generate 19.57% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Q2 Holdings  vs.  COSCIENS Biopharma

 Performance 
       Timeline  
Q2 Holdings 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Q2 Holdings are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of very abnormal basic indicators, Q2 Holdings displayed solid returns over the last few months and may actually be approaching a breakup point.
COSCIENS Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days COSCIENS Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong fundamental indicators, COSCIENS Biopharma is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.

Q2 Holdings and COSCIENS Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Q2 Holdings and COSCIENS Biopharma

The main advantage of trading using opposite Q2 Holdings and COSCIENS Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Q2 Holdings position performs unexpectedly, COSCIENS Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in COSCIENS Biopharma will offset losses from the drop in COSCIENS Biopharma's long position.
The idea behind Q2 Holdings and COSCIENS Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Bonds Directory
Find actively traded corporate debentures issued by US companies
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets